Cargando…

Evaluation of Predictive and Prognostic Importance of Lung Immune Prognostic Index in Locally Advanced Rectal Cancer Patients Treated With Neoadjuvant Chemoradiotherapy

Objective: The systemic inflammatory response (SIR) is known as an important factor associated with tumorigenesis and tumor progression, and can be reflected by inflammatory markers. One of the markers that reflect this is the lung immune prognostic index (LIPI). It is based on a derived neutrophil-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arıkan, Rukiye, Alkış, Hilal, Işık, Selver, Yaşar, Alper, Çelebi, Abdussamet, Majidova, Nargiz, Sever, Nadiye, Adlı, Mustafa, Demircan, Nazım C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Radiation Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350655/ https://www.ncbi.nlm.nih.gov/pubmed/37465788 http://dx.doi.org/10.7759/cureus.40548

Ejemplares similares

PNI as a Potential Add-On Biomarker to Improve the IMDC Intermediate Prognostic Score
por: Bayoğlu, İbrahim Vedat, et al.
Publicado: (2023)

Prognostic significance of mucinous histology in left‑sided metastatic colorectal cancers with wild‑type RAS and evaluation of backbone chemotherapy regimens
por: Arikan, Rukiye, et al.
Publicado: (2023)

The CONUT score is prognostic in esophageal cancer treated with chemoradiotherapy
por: Demir, Metin, et al.
Publicado: (2022)

Neoadjuvant chemoradiotherapy determines the prognostic impact of anastomotic leakage in advanced rectal cancer
por: Oh, Bo Young, et al.
Publicado: (2022)

The prognostic role of EZH2 expression in rectal cancer patients treated with neoadjuvant chemoradiotherapy
por: Meng, Xiangjiao, et al.
Publicado: (2014)

Prognostic and staging value of tumor deposits in patients with rectal cancer after neoadjuvant chemoradiotherapy
por: Xu, Tianlei, et al.
Publicado: (2021)

Prognostic significance of clinical and pathological stages on locally advanced rectal carcinoma after neoadjuvant chemoradiotherapy
por: Wen, Bixiu, et al.
Publicado: (2015)

Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy
por: Shen, Jinwen, et al.
Publicado: (2017)

Differences in prognostic relevance of rectal magnetic resonance imaging findings before and after neoadjuvant chemoradiotherapy
por: Song, Kwang-Seop, et al.
Publicado: (2019)

Poor prognostic and staging value of tumor deposit in locally advanced rectal cancer with neoadjuvant chemoradiotherapy
por: Wang, Yaqi, et al.
Publicado: (2019)

Do pathological variables have prognostic significance in rectal adenocarcinoma treated with neoadjuvant chemoradiotherapy and surgery?
por: Reggiani Bonetti, Luca, et al.
Publicado: (2017)

The prognostic impact of neoadjuvant chemoradiotherapy on lymph node sampling in patients with locally advanced rectal cancer
por: Li Destri, Giovanni, et al.
Publicado: (2020)

Evaluation of treatment response and tissue necrosis as prognostic indicators following neoadjuvant chemoradiotherapy in rectal cancer patients
por: Jung, Ji-Han, et al.
Publicado: (2016)

Prognostic Value of the FOXK Family Expression in Patients with Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy
por: Zhang, Yiyi, et al.
Publicado: (2020)

Prognostic Impact of Carcinoembryonic Antigen Levels in Rectal Cancer Patients Who Had Received Neoadjuvant Chemoradiotherapy
por: Joo, Jung Il, et al.
Publicado: (2021)

Prognostic Value of the Distribution of Lymph Node Metastasis in Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiotherapy
por: Chen, Bin, et al.
Publicado: (2021)

The combination of pre-neoadjuvant chemoradiotherapy inflammation biomarkers could be a prognostic marker for rectal cancer patients
por: Zhang, Jing, et al.
Publicado: (2022)

GRP78 Protein Expression as Prognostic Values in Neoadjuvant Chemoradiotherapy and Laparoscopic Surgery for Locally Advanced Rectal Cancer
por: Lee, Hee Yeon, et al.
Publicado: (2015)

Prognostic value of pretreatment systemic inflammatory markers in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy
por: Zhang, Yiyi, et al.
Publicado: (2020)

Log odds of positive lymph nodes is an excellent prognostic factor for patients with rectal cancer after neoadjuvant chemoradiotherapy
por: Xu, Tianlei, et al.
Publicado: (2021)

Restaging rectal cancer following neoadjuvant chemoradiotherapy
por: Cuicchi, Dajana, et al.
Publicado: (2023)

Skeletal muscle loss is an independent negative prognostic factor in patients with advanced lower rectal cancer treated with neoadjuvant chemoradiotherapy
por: Takeda, Yasuhiro, et al.
Publicado: (2018)

Clinical and Prognostic Significance of Pathological and Inflammatory Markers in Mucinous Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy and Curative Surgery
por: Zhao, Jian, et al.
Publicado: (2017)

Elevated CA19-9 as the Most Significant Prognostic Factor in Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy
por: Zhang, Lu-Ning, et al.
Publicado: (2015)

BMI May Be a Prognostic Factor for Local Advanced Rectal Cancer Patients Treated with Long-Term Neoadjuvant Chemoradiotherapy
por: Liu, Hengchang, et al.
Publicado: (2020)

A prognostic nomogram for stage II/III rectal cancer patients treated with neoadjuvant chemoradiotherapy followed by surgical resection
por: Lin, Yanfei
Publicado: (2022)

The modified Glasgow prognostic score is a reliable predictor of oncological outcomes in patients with rectal cancer undergoing neoadjuvant chemoradiotherapy
por: Shimada, Atsushi, et al.
Publicado: (2023)

Elevated CXCL12 in the plasma membrane of locally advanced rectal cancer after neoadjuvant chemoradiotherapy: a potential prognostic marker
por: Kim, Sup, et al.
Publicado: (2022)

Difference in prognostic impact of lateral pelvic lymph node metastasis between pre- and post-neoadjuvant chemoradiotherapy in rectal cancer patients
por: Lim, Byeo Lee, et al.
Publicado: (2023)

A Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
por: Li, Yi, et al.
Publicado: (2016)

Recent advances in neoadjuvant chemoradiotherapy in locally advanced rectal cancer
por: Kawai, Kazushige, et al.
Publicado: (2018)

Neoadjuvant FOLFIRINOX followed by Chemoradiotherapy for Middle and Lower Rectal Cancer
por: Sakr, Amr, et al.
Publicado: (2020)

Prognostic Value of Tissue-Resident Memory T Cells and Tumor Microenvironmental Features in Resected Pancreatic Adenocarcinoma
por: Başoğlu, Tuğba, et al.
Publicado: (2022)

Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
por: Lin, Huaqin, et al.
Publicado: (2021)

The prognostic impact of preoperative blood monocyte count in pathological T3N0M0 rectal cancer without neoadjuvant chemoradiotherapy
por: Zhang, Lu-Ning, et al.
Publicado: (2015)

Prognostic Impact of Pretreatment Elevated and Normalized Carcinoembryonic Antigen Levels After Neoadjuvant Chemoradiotherapy in Resected Locally Advanced Rectal Cancer Patients
por: Song, Jianyuan, et al.
Publicado: (2021)

Prognostic value of mesorectal package area in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy: A retrospective cohort study
por: Guan, Bingjie, et al.
Publicado: (2022)

Prognostic Significance of Tumor Regression Grade after Preoperative Chemoradiotherapy for Rectal Cancer
por: Kim, Byung Chun
Publicado: (2011)

Prognostic value of CEA and CA19-9 in patients with local advanced rectal cancer receiving neoadjuvant chemoradiotherapy, radical surgery and postoperative chemotherapy
por: Shan, Jingjing, et al.
Publicado: (2021)

Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study
por: Molinari, Chiara, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_1duho0m7911mfrv87n3njbfvjl